Home >> Antibodies >> Lewis Y (Tumor Marker)

Lewis Y (Tumor Marker)

Mouse Monoclonal Antibody [Clone A70-A/A9]

Printable

Key References

Bioinformatics

Catalog #

Size

20 ug

100 ug

Price (USD)

199.00

429.00

Formulation

Purified Ab with BSA and Azide at 200ug/ml

Purified Ab WITHOUT BSA and Azide at 1.0mg/ml

Performance Guarantee

Catalog No

Size

20 ug

100 ug

Formulation

Purified Ab with BSA and Azide at 200ug/ml

Purified Ab WITHOUT BSA and Azide at 1.0mg/ml

Price (USD)

199.00

429.00

Printable

Key References

Bioinformatics

Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with Lewis Y Mouse Monoclonal Antibody (A70-A/A9).

SDS-PAGE Analysis Purified Lewis Y Mouse Monoclonal Antibody (A70-A/A9). Confirmation of Purity and Integrity of Antibody.

Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with Lewis Y Mouse Monoclonal Antibody (A70-A/A9).

SDS-PAGE Analysis Purified Lewis Y Mouse Monoclonal Antibody (A70-A/A9). Confirmation of Purity and Integrity of Antibody.

Product Details

Synonyms

Lewis Y antigen

Positive Control

Lung, Colon, Bladder or Hepatocellular Carcinoma.

Known Applications & Suggested Dilutions

Flow Cyt, IF, IHC-P More Details

Flow Cytometry (1-2ug/million cells)
Immunofluorescence (1-2ug/ml)
Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes)
Optimal dilution for a specific application should be determined.

Immunogen

Live Ls174T cells (human colon carcinoma cell line)

Cellular Localization

Cell membrane, cytoplasmic and extracellular

Species Reactivity

Human.

Host / Ig Isotype

Mouse / IgG1, kappa

Mol. Weight of Antigen

Multiple

Specificity & Comments

This antibody recognizes a carbohydrate epitope present on tumor-associated Lewis Y antigen (Fucalpha1-2Galbeta1-4/3[Fucalpha1-3/4]GlcNAcbeta-). Lewis Y is expressed in large bowel tumors and colorectal carcinomas. It may be useful in the classification of human renal and bladder tumors. The Lewis Y antigen has been evaluated as a clinical marker for the diagnosis and prognosis of cholangiocarcinoma, hepatocellular carcinoma and breast cancer.